Pharma aims to deliver personalized cancer therapies more quickly
Big pharmaceutical companies that make personalized blood cancer treatments are working to cut the manufacturing turnaround time by as much as half in coming
July 24, 2024Big pharmaceutical companies that make personalized blood cancer treatments are working to cut the manufacturing turnaround time by as much as half in coming
July 24, 2024Germany's Merck on Friday raised its forecast for the group, mainly driven by a strong operating performance at its healthcare and electronics units.
July 26, 2024Mayne Pharma has filed a lawsuit against India's Sun Pharma over infringements of patents related to a certain product used for menopause-related vaginal pain, the Australian drugmaker said
July 24, 2024Anglo-Swedish drugmaker AstraZeneca raised its full year sales and profit forecast on Thursday after beating analyst expectations for second-quarter
July 25, 2024Swiss contract drug manufacturer Lonza reported a smaller-than-expected decline in first-half profit on Thursday, as a strong performance in its core
July 25, 2024Sanofi on Thursday raised its full-year profit outlook after strong demand for blockbuster asthma drug Dupixent and better-than-expected sales of new launches helped its
July 25, 2024Roche on Thursday raised its full-year earnings forecast after exceeding expectations for the first half, driven by strong demand for newer drugs such as eye
July 25, 2024The European Medicines Agency has backed the use of Novo Nordisk's Wegovy to lower major heart risks and strokes in overweight or obese adults without diabetes, the Danish drugmaker said on
July 25, 2024Indian drugmaker Mankind Pharma said late on Thursday it would acquire Bharat Serums and Vaccines Ltd in a deal valued at around 136.30 billion rupees ($1.63 billion), including debt.
July 25, 2024Cipla, India's third-largest generics drugmaker by sales, beat first-quarter profit estimates on Friday as it reported higher sales in its North
July 26, 2024A major Pfizer pharmaceutical plant has restarted production, 10 weeks after it was heavily damaged by a tornado
September 25, 2023Japan’s health ministry has approved Leqembi, a drug for Alzheimer’s decease that was jointly developed by Japanese and U.S. pharmaceutical companies
September 26, 2023Eli Lilly and Co and a former employee agreed to settle a lawsuit in which the worker claimed she was terminated after pointing out poor manufacturing
April 26, 2024Global health aid agency Unitaid has written to Johnson & Johnson's (J&J) CEO Joaquin Duato, urging him to take "immediate action" to expand access to the company's tuberculosis
April 26, 2024A U.S.
April 26, 2024All the drugmakers that make the 10 prescription medicines subject to the first-ever price negotiations for the U.S.
April 26, 2024Eli Lilly and Co has agreed to acquire Point Biopharma Global in an all-cash deal valued at $1.4 billion, the two companies said on Tuesday.
April 26, 2024Eli Lilly and Co said on Wednesday that the head of its diabetes and obesity division, Mike Mason, will retire by the end of the year after more than three decades with the drugmaker.
April 26, 2024Paris-based drugmaker Sanofi is exploring a potential acquisition of cancer drugmaker Mirati Therapeutics, Bloomberg News reported on Thursday citing people familiar with the matter.
April 26, 2024Americans have started rolling up their sleeves for the latest version of the COVID-19 vaccine, but weeks into the rollout some
April 26, 2024California Gov. Gavin Newsom has vetoed a bill aimed at limiting the price of insulin
October 08, 2023Bristol-Myers Squibb is set to acquire cancer drugmaker Mirati Therapeutics for $58 per share in cash, representing $4.8 billion equity value.
April 26, 2024Contract drug manufacturers seeking to tap into the booming market for weight-loss drugs are investing billions of dollars to expand or build factories that fill the
April 26, 2024Shares of dialysis service providers fell sharply on Wednesday after Novo Nordisk's Ozempic showed early signs of success in delaying the progression of kidney disease in
April 26, 2024Pfizer Inc on Friday cut forecast for 2023 revenue to between $58 billion and $61 billion, from $67 billion to $70 billion previously.
April 26, 2024